Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Medtronic
Colorcon
Moodys
McKinsey

Last Updated: May 25, 2022

Graviti Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?

GRAVITI PHARMS has twelve approved drugs.



Summary for Graviti Pharms
US Patents:0
Tradenames:12
Ingredients:12
NDAs:12

Drugs and US Patents for Graviti Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Graviti Pharms DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 202114-001 Jul 5, 2013 AB RX No No See Plans and Pricing See Plans and Pricing
Graviti Pharms GABAPENTIN gabapentin CAPSULE;ORAL 207099-003 Mar 24, 2017 AB RX No No See Plans and Pricing See Plans and Pricing
Graviti Pharms TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; tramadol hydrochloride TABLET;ORAL 076914-001 Jul 26, 2006 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Medtronic
Colorcon
Express Scripts
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.